Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > 9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate
9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate structure, CAS 206184-49-8

9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate

CAS Number206184-49-8

SynonymsTenofovir Monohydrate; Unii-99yxe507il; 9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate; Tenofovir hydrate; Tenofovir (hydrate)

Molecular FormulaC9H16N5O5P

Molecular Weight305.23

Purity98.00%

Density1.79g/cm3

Boiling Point616.1ºC at 760mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9055371 Purity: 98.00%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 206184-49-8 ] Purity: 98.00% SDS Specification MoL

Chemical & Physical Properties
CAS Number206184-49-8
Catalog No.2A-9055371
Chinese Name9-[(R)-2-(磷酰甲氧基)丙基]腺嘌呤
SynonymsTenofovir Monohydrate; Unii-99yxe507il; 9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate; Tenofovir hydrate; Tenofovir (hydrate)
Molecular FormulaC9H16N5O5P
Molecular Weight305.23
Purity98.00
Density1.79g/cm3
Boiling Point616.1ºC at 760mmHg
Storage Condition2-8℃
ApplicationTenofovir hydrate is a nucleotide reverse transcriptase inhibitor used to treat HIV and chronic hepatitis B.
HTC2933990090
MDL NumberMFCD11519982
SMILES[P](=O)(O)(O)CO[C@@H](C[n]1c2ncnc(c2nc1)N)C.O
InChI1S/C9H14N5O4P.H2O/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14;/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17);1H2/t6-;/m1./s1
InChI KeyPINIEAOMWQJGBW-FYZOBXCZSA-N
NACRES CodeNA.24
UNSPSC41116107
MSDSmsds/55371_1_206184_49_8.pdf
Use ofTenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B. Properties Name tenofovir hydrate Synonym More Synonyms Tenofovir Monohydrate Biological Activity Description Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B. Related Catalog Signaling Pathways >> Anti-infection >> HIV Signaling Pathways >> Anti-infection >> Reverse Transcriptase Research Areas >> Infection References [2]. Musumeci G, et al. M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures. Sci Rep. 2017 Feb 1;7:41018. [3]. Wahl A, et al. Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model. Sci Rep. 2017 Feb 1;7:41098. [4]. Menne S, Cote PJ, Korba BE, Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother. 2005 Jul;49(7):2720-8. Chemical & Physical Properties Molecular Formula C9H16N5O5P Exact Mass 305.08900 PSA 155.42000 LogP 0.46570 InChIKey PINIEAOMWQJGBW-FYZOBXCZSA-N Storage condition 2-8℃ Safety Information Signal Word Danger Hazard Statements H301 Precautionary Statements Missing Phrase - N15.00950417 RIDADR NONH for all modes of transport HS Code 2933990090
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA